Biomedical Diagnostics Institute (BDI)
At a Glance
- Status: Active Consortium
- Year Launched: 2005
- Initiating Organization: Science Foundation Ireland
- Initiator Type: Government
- No disease focus
- Location: Europe
The Biomedical Diagnostics Institute (BDI) is a Science Foundation Ireland Centre for Science, Engineering and Technology (CSET). Established in October 2005, BDI is an academic-business-clinical partnership that sponsors research programs focused on the development of next-generation biomedical diagnostic devices.
The BDI vision is to transform healthcare by pioneering advances in the science and technology of diagnostics and by translating these advances into clinical use.
BDI’s primary objectives are to
- sustain and grow a world-renowned center of excellence in biomedical diagnostics
- pioneer advances in the science and technology of diagnostics
- translate its research outputs into clinical application by working closely with commercial and clinical partners
- ensure that its various outputs impart both societal and economic benefits to Ireland
- develop cost-effective diagnostic devices for low-resource environments
- provide highly skilled researchers to contribute to a vibrant industry sector
- stimulate an enduring interest in science and technology in students of all ages, as well as enhance public understanding of science
- Point of Care
- Home healthcare monitoring
- Link therapy and monitoring (companion diagnostics)
BDI research addresses major clinical challenges informed by the partnership of clinicians, scientists, and industry. Building on key scientific insights, BDI will apply its established capabilities to create integrated Point-of-Care solutions, which will have major impacts on diagnosing disease and sustaining human health.
Established in October 2005, BDI is an academic-industrial-clinical partnership that carries out cutting-edge research programs focused on the development of next-generation biomedical diagnostic devices.
BDI was seeded with €19.1 million from Science Foundation Ireland and associated funding from industry partners.
BDI has generated a strong portfolio of intellectual property (IP), borne out of the diverse technical disciplines that come together in its research strands. The BDI IP portfolio includes cutting-edge devices and methodologies in microfluidics, molecular assays and signal detection, novel biomarkers of disease, and know-how pertaining to the generation and optimization of customized antibodies.
BDI has generated a portfolio of IP created through the collaborations. Several of its inventions have made it to the commercial market with CE Marking.
Points of Contact
Dr. Georgina Murphy
phone: 01 700 8919
Dr. Conor Burke
Associate Director (Commercialisation)
Biomedical Diagnostics Institute, DCU
phone: +353 1 700 8061
fax: +353 1 700 8021
Sponsors & Partners
Analog Devices Inc.
Becton Dickinson and Co.
Dublin City University
Galway University Hospital
Inverness Medical Innovations
National University of Ireland, Galway
Royal College of Surgeons in Ireland
St. James Hospital
The Tyndall National Institute at University College, Cork
Trinity College, Dublin